Cargando…
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML
Forkhead box protein M1 (FOXM1) is a crucial regulator of cancer development and chemoresistance. It is often overexpressed in acute myeloid leukemia (AML) and is associated with poor survival and reduced efficacy of cytarabine therapy. Molecular mechanisms underlying high FOXM1 expression levels in...
Autores principales: | Chesnokov, Mikhail S, Borhani, Soheila, Halasi, Marianna, Arbieva, Zarema, Khan, Irum, Gartel, Andrei L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350342/ https://www.ncbi.nlm.nih.gov/pubmed/34381718 http://dx.doi.org/10.3389/fonc.2021.696532 |
Ejemplares similares
-
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
por: Chesnokov, Mikhail S., et al.
Publicado: (2021) -
Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage
por: Halasi, Marianna, et al.
Publicado: (2012) -
Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018) -
FoxM1 Is a General Target for Proteasome Inhibitors
por: Bhat, Uppoor G., et al.
Publicado: (2009) -
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
por: Bhat, Uppoor G., et al.
Publicado: (2009)